Relmada Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024
CORAL GABLES, Fla., May 6, 2024 /PRNewswire/ -- Relmada Therapeutics, Inc. , a late-stage biotechnology company addressing diseases of the central nervous system , today announced that it will...
Source: marketscreener.com